Exercise and triple negative breast cancer: Unravelling the anti-neoplastic molecular factors through novel culture method

被引：1
|
作者：
Dela Cruz, M. A. [1 ]
Roy, P. [1 ]
Chowdhury, S. [1 ]
Chan, S. [1 ]
Roy, H. K. [1 ]
机构：
[1] Boston Univ, Med Ctr, Boston, MA USA
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P3-07-18
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-07-18
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer
    Sturtz, Lori A.
    Melley, Jen
    Mamula, Kim
    Shriver, Craig D.
    Ellsworth, Rachel E.
    BMC CANCER, 2014, 14
  • [22] Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing
    Chen, Yan-li
    Wang, Ke
    Xie, Fei
    Zhuo, Zhong-ling
    Liu, Chang
    Yang, Yu
    Wang, Shu
    Zhao, Xiao-tao
    CLINICA CHIMICA ACTA, 2022, 531 : 302 - 308
  • [23] The anti-neoplastic effects of metformin modulate the acquired phenotype of fibroblast cells in the breast cancer-normal fibroblast co-culture system
    Mostafavi, Samaneh
    Hassan, Zuhair mohammad
    ONCOLOGY RESEARCH, 2024, 32 (03) : 477 - 487
  • [24] A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy
    D'Avino, Chiara
    Palmieri, Dario
    Braddom, Ashley
    Zanesi, Nicola
    James, Cindy
    Cole, Sara
    Salvatore, Francesco
    Croce, Carlo M.
    De Lorenzo, Claudia
    ONCOTARGET, 2016, 7 (52) : 87016 - 87030
  • [25] Predicting locoregional recurrence in triple-negative breast cancer using novel molecular subtyping.
    Shao, Shali
    Shi, Wei
    Zhang, Li
    Zhang, Qixian
    Meng, Jin
    Yang, Zhaozhi
    Mei, Xin
    Chen, Xingxing
    Ma, Jinli
    Mo, Miao
    Shao, Zhimin
    Zhang, Zhen
    Guo, Xiaomao
    Yu, XiaoLi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Unravelling the role of PKC-eta in modulating the Hippo Pathway: a novel therapeutic strategy for triple-negative breast cancer metastasis
    Belsamma, Liju Vijaya Steltar
    Muraleedharan, Amitha
    Jayaram, Divya Ram
    Waidha, Kamran
    Jagadeeshan, Sankar
    Sinay, Rose
    Eremenko, Ekaterina
    Berner, Omer
    Elkabets, Moshe
    Livneh, Etta
    CANCER RESEARCH, 2024, 84 (09)
  • [27] MOLECULAR ANALYSIS OF RESECTED BREAST CANCER BRAIN METASTASES REVEALS CEREBELLAR LOCATION AND TRIPLE NEGATIVE SUBTYPE ARE NEGATIVE PROGNOSTIC FACTORS
    Huppert, Laura
    Salans, Mia
    Kuwahara, Kelsey
    Zhou, Maggie
    Boreta, Lauren
    Braunstein, Steve
    Melisko, Michelle
    Aghi, Manish
    Morshed, Ramin
    Vasudevan, Harish
    NEURO-ONCOLOGY, 2024, 26
  • [28] Mapping Novel Metabolic Nodes Targeted by Anti-Cancer Drugs that Impair Triple-Negative Breast Cancer Pathogenicity
    Roberts, Lindsay S.
    Yan, Peter
    Bateman, Leslie A.
    Nomura, Daniel K.
    ACS CHEMICAL BIOLOGY, 2017, 12 (04) : 1133 - 1140
  • [29] Pim3 kinase is a poor prognostic marker and novel molecular target for triple negative breast cancer
    Atalay, Pinar
    Kara, Goknur
    Ozyurt, Rumeysa
    Kahraman, Nermin
    Ozpolat, Bulent
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Anti-triple-negative breast cancer metastasis efficacy and molecular mechanism of the STING agonist for innate immune pathway
    Lu, Xing
    Wang, Xiang
    Cheng, Hao
    Wang, Xiaoqing
    Liu, Chang
    Tan, Xiangshi
    ANNALS OF MEDICINE, 2023, 55 (01)
12345